Armistice Capital, LLC 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Armistice Capital, LLC disclosed 357 US equity positions worth $4.1bn in its Q4 2025 13F filing. The largest position was PTCT at 5.2% of the reported book, followed by MDGL and IMVT. Against the Q3 2025 filing, it opened 2 new positions, added to 34 and reduced 11 among the top 50 holdings.
What did Armistice Capital, LLC own in Q4 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | PTCT PTC THERAPEUTICS INC | Healthcare | 5.2% | $212.8m | 2,801,869 | -15% | reduced |
| 2 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 3.8% | $154.7m | 265,705 | 121% | added |
| 3 | IMVT IMMUNOVANT INC | Healthcare | 3.6% | $146.1m | 5,747,155 | -2% | reduced |
| 4 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 3.5% | $143.8m | 3,763,891 | -44% | reduced |
| 5 | SUPN SUPERNUS PHARMACEUTICALS INC | Healthcare | 3.4% | $137.4m | 2,764,000 | -3% | reduced |
| 6 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.8% | $116.3m | 820,240 | 18% | added |
| 7 | INCY INCYTE CORP | Healthcare | 2.7% | $108.5m | 1,098,102 | -6% | reduced |
| 8 | AMZN AMAZON COM INC | Consumer Cyclical | 2.1% | $84.9m | 367,633 | 19% | added |
| 9 | XRAY DENTSPLY SIRONA INC | Healthcare | 2.0% | $83.4m | 7,298,000 | 27% | added |
| 10 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 2.0% | $82.6m | 3,036,000 | 297% | added |
| 11 | FRPT FRESHPET INC | Consumer Defensive | 1.9% | $79.0m | 1,296,000 | 5% | added |
| 12 | KVUE KENVUE INC | Consumer Defensive | 1.7% | $68.9m | 3,992,196 | – | new |
| 13 | GEHC GE HEALTHCARE TECHNOLOGIES I | Healthcare | 1.6% | $65.0m | 792,000 | -0% | held |
| 14 | REGN REGENERON PHARMACEUTICALS | Healthcare | 1.6% | $64.8m | 84,000 | -33% | reduced |
| 15 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.6% | $63.6m | 3,249,708 | 6% | added |
| 16 | CYTK CYTOKINETICS INC | Healthcare | 1.5% | $63.1m | 992,766 | -17% | reduced |
| 17 | GOOGL ALPHABET INC | Communication Services | 1.5% | $61.5m | 196,420 | -15% | reduced |
| 18 | MSFT MICROSOFT CORP | Technology | 1.4% | $57.2m | 118,337 | 36% | added |
| 19 | IRWD IRONWOOD PHARMACEUTICALS INC | Healthcare | 1.3% | $54.0m | 16,025,000 | -1% | reduced |
| 20 | KURA KURA ONCOLOGY INC | Healthcare | 1.3% | $51.3m | 4,936,000 | 6% | added |
| 21 | ELF E L F BEAUTY INC | Consumer Defensive | 1.2% | $50.0m | 657,983 | 395% | added |
| 22 | GSK GSK PLC | Healthcare | 1.2% | $49.0m | 1,000,000 | – | new |
| 23 | ARGX ARGENX SE | Healthcare | 1.2% | $48.8m | 58,000 | 0% | held |
| 24 | BABA ALIBABA GROUP HLDG LTD | Consumer Cyclical | 1.1% | $46.8m | 319,100 | 105% | added |
| 25 | SBUX STARBUCKS CORP | Consumer Cyclical | 1.1% | $46.3m | 549,805 | 54% | added |
| 26 | PENN PENN ENTERTAINMENT INC | Consumer Cyclical | 1.1% | $45.7m | 3,096,000 | 47% | added |
| 27 | OFIX ORTHOFIX MED INC | Healthcare | 1.0% | $40.1m | 2,648,000 | 18% | added |
| 28 | FIVN FIVE9 INC | Technology | 1.0% | $40.1m | 2,000,000 | 0% | held |
| 29 | IRON DISC MEDICINE INC | Healthcare | 1.0% | $39.7m | 499,391 | 15% | added |
| 30 | IMCR IMMUNOCORE HLDGS PLC | Healthcare | 0.9% | $38.1m | 1,098,000 | 33% | added |
| 31 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 0.9% | $36.4m | 62,838 | 14% | added |
| 32 | S SENTINELONE INC | Technology | 0.9% | $36.3m | 2,422,219 | 118% | added |
| 33 | 8HH AVANOS MED INC | 0.9% | $35.9m | 3,200,000 | 28% | added | |
| 34 | RIGL RIGEL PHARMACEUTICALS INC | 0.9% | $35.8m | 836,000 | 15% | added | |
| 35 | AUTL AUTOLUS THERAPEUTICS PLC | Healthcare | 0.9% | $34.8m | 17,500,000 | 12% | added |
| 36 | ISRG INTUITIVE SURGICAL INC | Healthcare | 0.8% | $34.6m | 61,073 | 49% | added |
| 37 | DDOG DATADOG INC | Technology | 0.8% | $33.3m | 244,537 | 21% | added |
| 38 | VERA VERA THERAPEUTICS INC | Healthcare | 0.8% | $33.1m | 653,796 | 22% | added |
| 39 | SNY SANOFI SA | 0.8% | $32.8m | 676,000 | 10% | added | |
| 40 | GTLB GITLAB INC | Technology | 0.8% | $32.2m | 858,925 | 128% | added |
| 41 | AXGN AXOGEN INC | Healthcare | 0.8% | $30.6m | 936,000 | -22% | reduced |
| 42 | ANRO ALTO NEUROSCIENCE INC | Healthcare | 0.7% | $27.3m | 1,536,000 | -6% | reduced |
| 43 | VSTM VERASTEM INC | Healthcare | 0.7% | $27.3m | 3,536,000 | 69% | added |
| 44 | HUBS HUBSPOT INC | Technology | 0.7% | $27.3m | 68,000 | 51% | added |
| 45 | MDT MEDTRONIC PLC | Healthcare | 0.6% | $26.1m | 271,241 | 2% | added |
| 46 | GRFS GRIFOLS S A | Healthcare | 0.6% | $25.9m | 2,768,000 | 24% | added |
| 47 | NKTR NEKTAR THERAPEUTICS | Healthcare | 0.6% | $25.2m | 596,000 | 122% | added |
| 48 | NKE NIKE INC | Consumer Cyclical | 0.6% | $25.1m | 394,709 | 399% | added |
| 49 | PATH UIPATH INC | Technology | 0.6% | $25.0m | 1,524,617 | 13% | added |
| 50 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.6% | $24.5m | 676,035 | 33% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.